Evaluating Drug Eruptions Using AI: Tips From Alina G. Bridges, DO
Cutis · 01.05.2026 · 5 (117)
DOI: 10.12788/cutis.1386 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cutis, erschienen am 01.05.2026. Verfasst von Alina G Bridges und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Bridges is from the Donald and Barbara Zucker School of Medicine at Hofstra/ Northwell, Lake Success, New York.
Abstract (Originalsprache)
Artificial intelligence (AI) is a promising adjunct in dermatopathology, enhancing detection of subtle histologic features in drug eruptions and enabling standardized quantification through whole-slide image analysis. Techniques such as attention-based models and heatmap generation may highlight focal or overlooked findings, but drug eruption–specific validation remains limited. Cutis board member Alina G. Bridges, DO, discusses AI’s role as an assistive tool, emphasizing explainability, human oversight, documentation
Autor:innen und Institutionen
- Dr. Bridges is from the Donald and Barbara Zucker School of Medicine at Hofstra/ Northwell, Lake Success, New York.
Zitieren
APA
Bridges, A. G., Jacobs, J., & Sonners, A. (2026). Evaluating Drug Eruptions Using AI: Tips From Alina G. Bridges, DO. Cutis, 5(117). https://doi.org/10.12788/cutis.1386
Vancouver
Bridges AG, Jacobs J, Sonners A. Evaluating Drug Eruptions Using AI: Tips From Alina G. Bridges, DO. Cutis. 2026;5(117). doi:10.12788/cutis.1386
BibTeX
@article{Bridges2026,
author = {Bridges, Alina G and Jacobs, Jeanelle and Sonners, Alicia},
title = {Evaluating Drug Eruptions Using AI: Tips From Alina G. Bridges, DO},
journal = {Cutis},
year = {2026},
volume = {5},
number = {117},
doi = {10.12788/cutis.1386}
}
EUVIMED